BSEGlen Industries Ltd· Industrial ProductsHighNegative
Announced Fri, 30 Jan, 2026 · 17:35 IST

Postponement in commencement of commercial production.

Capex DelayedCapex & Operations View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.3%Reaction day
₹75.77
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-1.1% vs market
Packaging peers, median of 60sector-0.9%-1.4% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.4 pts less than its Packaging peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.3-1.3-1.1-0.9-1.4
Next day
-2.1+2.4-4.5+1.3-3.4
2d
+0.7+3.8-3.1+1.7-1.0
3d
+0.7+2.7-2.0+2.4-1.7
4d
+0.3+1.9-1.6+1.2-0.9
5d
+4.3+4.6-0.3+4.4-0.1
1w
+6.9+5.1+1.8+4.2+2.7
15d
+2.3+2.1+0.2+0.1+2.2
1m
-4.3-2.1-2.2-3.0-1.3
2m
-12.9-6.4-6.5-10.1-2.8
3m
-1.0+9.5-10.5+1.6-2.6
UpDownMarket · Nifty Microcap 250Sector · Packaging peers, median of 60Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Glen Industries has postponed the start of its commercial production due to delays in receiving approvals from regulatory authorities. As per its Red Herring Prospectus, production was originally expected to begin by Q4 of FY 2025–26, but the new timeline is Q1/Q2 of FY 2026–27. The company has stated that the delay is procedural in nature and is not expected to materially affect its business or financials. It is actively following up with the relevant authorities to obtain the pending approvals. The company appears to be a recently listed entity, suggesting the delayed plant is a key growth driver tied to its IPO plans.

Likely market impact

Pushes back revenue generation from the new facility by about 2–3 quarters, which could weigh on near-term stock sentiment. However, the company has downplayed the impact as procedural and non-material, so long-term thesis remains intact if approvals come through on time.